New formulation of FDA-approved drug shows encouraging results for treating a common itch condition
Notalgia paresthetica—a nerve disorder characterized by a persistent itch in the upper back—is a common and underdiagnosed condition worldwide. To date, there are no FDA-approved treatments specifically targeting this ...
Feb 8, 2023
0
138